Telemetry Investments’s Array Biopharma Inc ARRY Stock Holding History

Telemetry Investments’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-50,000	Closed	-$418K	–	157
2017 Q2	$418K	Buy	50,000 +40,000	+400%	+$327K	0.2%	73
2017 Q1	$89K	Sell	10,000 -22,000	-69%	-$234K	0.04%	110
2016 Q4	$281K	Buy	+32,000	New	+$235K	0.16%	75

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Telemetry Investments's ARRY Position: Q3 2019 in Review

Telemetry Investments sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 6,500 shares — an estimated $301K sold.

Telemetry Investments first reported a position in ARRY in Q1 2015 and held it in 2 quarters. The position peaked at $936K in Q1 2015. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Telemetry Investments reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Telemetry Investments sold 6,500 Array Biopharma Inc shares in Q3 2019, an estimated $301K.
Telemetry Investments first reported a position in Array Biopharma Inc in Q1 2015 and held it in 2 quarters.
Telemetry Investments's Array Biopharma Inc position peaked at $936K in Q1 2015.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Telemetry Investments's 13F filing for Q3 2019, filed 14 Nov 2019.